Pentoxifylline promotes replication of human cytomegalovirus in vivo and in vitro

Blood

Volumn 89, Issue 10, 1997, Pages 3682-3690

  Staak, Kerstin ^a   Prösch, Susanna ^a   Stein, Joachim ^a   Priemer, Christina ^a   Ewert, Ralf ^a   Döcke, Wolf Dietrich ^a   Krüger, Detlev H ^a   Volk, Hans Dieter ^a   Reinke, Petra ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLXANTHINE; MONOCLONAL ANTIBODY; OKT 3; PENTOXIFYLLINE; TRANSCRIPTION FACTOR;

ANTIBODY PRODUCTION; ANTIGENICITY; ARTICLE; CYTOMEGALOVIRUS; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; STEM CELL; TRANSPLANTABLE SOLID TUMORS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 1842288619     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.10.3682     Document Type: Article

References (44)

1. Patel R, Snydman DR, Rubin RH, Ho M, Pescovicz M, Martin M, Paya CV: Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation 61:1279, 1996
2. Taylor-Wiedeman J, Sissons JGP, Borysiewicz LK, Sinclair JH: Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72:2059, 1991
3. Kondo K, Kaneshima H, Mocarski ES: Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci USA 91:11879, 1994
4. Minton EJ, Tysoe C, Sinclair JH, Sissons JGP: Human cytomegalovirus infection of the monocyte/macrophage lineage. J Virol 68:4017, 1994
5. Weinshenker BG, Wilton S, Rice GP: Phorbol ester-induced differentiation permits productive human Cytomegalovirus infection in a monocytic cell line. J Immunol 140:1625, 1988
6. Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Joer SC: Infection of hematopoietic progenitor cells by human Cytomegalovirus. Blood 80:170, 1992
7. Bitsch A, Kirchner H, Dupke R, Bein G: Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse transcription-polymerase chain reaction. J Infect Dis 167:740, 1993
8. Söderberg C, Larsson S, Bergstedt-Lindqvist S, Möller E: Definition of a subset of human peripheral blood mononuclear cells that are permissive to human Cytomegalovirus infection. J Virol 67:3166, 1993
9. Fietze E, Prösch S, Reinke P, Stein J, Döcke WD, Staffa G, Loening S, Emmrich F, von Baehr R, Krüger DH, Volk HD: Cytomegalovirus infection in transplant recipients: Role of tumor necrosis factor. Transplantation 58:675, 1994
10. Döcke WD, Prösch S, Fietze E, Kimel V, Zuckermann H, Kluge C, Syrbe U, Krüger DH, von Baehr R, Volk HD: Cytomegalovirus reactivation and tumor necrosis factor. Lancet 343:268, 1994
11. Stein J, Volk HD, Liebenthal C, Krüger DH, Prösch S: Tumor necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate-early enhancer/promoter in immature monocytic cells. J Gen Virol 74:2333, 1993
12. Prösch S, Staak K, Stein J, Liebenthal C, Stamminger T, Volk HD, Krüger DH: Stimulation of the HCMV immediate early enhancer/promoter in HL-60 cells by TNFα is mediated via activation of NF-kB. Virology 208:297, 1995
13. Zabel P, Schönharting MW, Wolter DT, Scháde FU: Oxpentifylline in endotoxinaemia. Lancet 24:1474, 1989
14. Zabel P, Scháde FU, Schlaak M: Pentoxifyllin-ein Synthesehemmer für Tumor-Nekrose-Faktor-alpha. Immun Infekt 20:80, 1991
15. Vincenti FG, Vasconcelos V, Birnbaum JL, Tomlanovich SJ, Amend WJ Jr, Melzer JR, Snyder JP: Pentoxifylline reduces the first-dose reaction following OKT3. Transplant Proc 25:57, 1993
16. Bessler H, Gilgal R, Djaldetti M, Zahavi I: Effect of pentoxifylline on the phagocytic activity, cAMP levels, and Superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol 40:747, 1986
17. Tannenbaum CS, Hamilton TA: Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. J Immunol 142:1274, 1989
18. Han J, Thompson P, Beutler B: Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 172:391, 1990
19. Waage A, Sorenson M, Strodahl B: Differential effects of pentoxifylline on tumor necrosis factor and interleukin-5 production. Lancet 3:543, 1990
20. Doherty GM, Jensen JC, Alexander R, Buresh CM, Norton JA: Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110:192, 1991
21. Reinke P, Fietze E, Döcke WD, Kern F, Ewert R, Volk HD: Late acute rejection in long-term renal allograft recipients-diagnostic and predictive value of circulating activated T cells. Transplantation 58:35, 1995
22. Fickenscher H, Stamminger T, Rüger R, Fleckenstein B: The role of a repetitive palindromic sequence element in the human Cytomegalovirus major immediate early enhancer. J Gen Virol 70:107, 1989
23. Stamminger T, Fickenscher H, Fleckenstein B: The cell type specific induction of the major immediate early enhancer of human Cytomegalovirus by cyclic AMP. J Gen Virol 71:105, 1990
24. tax of human T-cell leukemia virus type I via two repetitive taxresponsive sequence elements. J Virol 66:7346, 1992
25. Hunnighake GW, Monick MM, Lin B, Stinski M: The promoter-regulatory region of the major immediate-early genen of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J Virol 63:3026, 1989
26. Abramowics D, Schandene L, Goldman M, Cruisiaux A, Vereerstraeten P, DePauw L, Wybran J, Kinnaert P, Dupont E, Toussaint C: Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 47:606, 1989
27. Chatenoud L, Ferran C, Reuter A, Legendre C, Gevaert Y, Kreis H, Franchimont P, Bach JF: Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma. N Engl J Med 320:1420, 1989
28. Chatenoud L, Ferran C, Legendre C, Thouard I, Merite S, Reuter A, Gevaert Y, Kreis H, Franchimont P, Bach JF: In vivo activation following OKT3 administration: Systemic cytokine release and modulation by corticosteroids. Transplantation 49:697, 1990
29. Debets JMH, Leunissen KML, van Hooff HJ, van der Linden CJ, Buurman WA: Evidence of involvement of tumor necrosis factor in adverse reactions during treatment with antithymocyte globulin. Transplantation 47:487, 1989
30. Ferran C, Sheehan K, Dy M, Schreiber R, Merite S, Landais P, Noel LH, Grau G, Bluestone J, Bach JF: Cytokine-related syndrome following injection of anti-CD3 mnoclonal antibody: Further evidence for transient in vivo T cell activation. Eur J Immunol 20:509, 1990
31. Gaston RS, Deierhoi MH, Patterson T, Prasthofer E, Julian BA, Barber WH, Laskow DA, Diethelm AG, Curtis JJ: OKT3 first dose reaction: Association with T cell subsets and cytokine release. Kidney Int 39:141, 1991
32. Allegre ML, Gastaldello K, Abramowicz D, Kinnaert P, Vereerstaeten P, DePauw L, Vandenabeele P, Moser M, Lee O, Goldman M: Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome. Transplantation 52:674, 1991
33. Jewett A, Bonavida B: Pentoxifylline suppresses interleukin-2-mediated activation of immature human natural killer cells by inhibiting endogenous tumor necrosis factor-alpha secretion. J Clin Immunol 14:31, 1994
34. Bianco JA, Appelbaum FR, Nemunaitis J, Almgren J, Andrews F, Kettner P, Shields A, Singer JW: Phase I-II trials of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood 78:1205, 1991
35. Schandene L, Gérard C, Crusiaux A, Abramowicz D, Velu T, Goldman M: Interleukin-10 inhibits OKT3-induced cytokine release: In vitro comparison with pentoxifylline. Transplant Proc 25 55, 1993 (suppl)
36. DeVault GA, Kohan DE, Nelson EW, Holman JM: The effects of oral pentoxifylline on the cytokine release syndrome during inductive OKT3. Transplantation 57:532, 1994
37. Gonzalez GA, Montminy MR: Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59:675, 1989
38. Mellors JW, Griffith BP, Oritz MA, Landry ML, Ryan JL: Tumor necrosis factor α/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J Infect Dis 163:78, 1991
39. Osborn L, Kunkel S, Nabel GJ: Tumor necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc Natl Acad Sci USA 86:2336, 1989
40. Chowdhury IH, Koyanagi Y, Horiuchi S, Hazeki O, Ui M, Kitano K, Golde DW, Takada K, Yamamoto N: cAMP stimulates human immunodeficiency virus (HIV-1) from latently infected cells of monocyte-macrophage lineage: Synergism with TNFα. Virology 194:345, 1993
41. Fazley F, Dezube BJ, Allen-Ryan J, Pardee AB, Ruprecht RM: Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells. Blood 77:1654, 1991
42. Dezube BJ, Lederman MM, Spritzler JG, Chapman B, Korvick JA, Flexner C, Dando S, Mattiacci MR, Ahlers CM, Zhang L, Novick WJ, Kasdan P, Fahey JL, Pardee AB, Crumpacker CS, National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group: High-dose pentoxifylline in patients with AIDS: Inhibition of tumor necrosis factor production. J Infect Dis 171:1628, 1995
43. Dezube BJ: Pentoxifylline for the treatment of infection with human immunodeficiency virus. Clin Infect Dis 18:285, 1994
44. Dezube BJ, Pardee AB, Chapman B, Beckett LA, Korvick JA, Novick WJ, Chiurco J, Kasdan P, Ahlers CM, Ecto LT: Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. J AIDS 6:787, 1993